Action Petros Pharmaceuticals (PK) - PTPI

Petros Pharmaceuticals Inc (PK) (PTPI) Action

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

0,0055

( 7,63% )

Prix Achat

0,005

Prix Vente

0,0064

Volume échangé

77 535

0,0055 Fourchette du Jour 0,0055

0,0017 Plage de 52 semaines 0,0384

Cap du marché

233,047k

Clôture Veille

0,00511

Ouverture

0,0055

Dernière Transaction

0.0057

Dernière heure de transaction

16:49:29

Volume financier

US$ 426

VWAP

0,0055

Volume moyen (3 m)

US$ 96 395

Actions en circulation

42 372 260

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

-0,01

Bénéfice par action (BPA)

-0,86

Chiffre d'affairess (LTM)

Bénéfice net (LTM)

3,19M

Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary software as a service (SaaS) platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York. Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary software as a service (SaaS) platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York.

Secteur

Healthcare

Industrie

Pharmaceuticals

Site Web

petrospharma.com

Siège social

New York, United States

Fondé

Petros Pharmaceuticals Inc (PK) est coté dans le secteur Healthcare de la OTC Markets avec le ticker PTPI. Le dernier cours de clôture d'Petros Pharmaceuticals (PK) était de US$0,01. Au cours de la dernière année, les actions de Petros Pharmaceuticals (PK) ont été négociées dans une fourchette de prix de US$ 0,0017 à US$ 0,0384.

Petros Pharmaceuticals (PK) compte actuellement 42 372 260 actions en circulation. La capitalisation boursière d'Petros Pharmaceuticals (PK) est de US$233 047,43 . Petros Pharmaceuticals (PK) a un ratio cours/bénéfice (ratio PE) de -0.01.

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.0005	-8.33333333333	0.006	0.0073	0.0051	114107	0.00516201	CS
4	-0.0014	-20.2898550725	0.0069	0.0081	0.005	90399	0.00605027	CS
12	-7.5E-5	-1.34529147982	0.005575	0.01	0.005	104727	0.00654511	CS
26	-0.00236	-30.0254452926	0.00786	0.01	0.005	104221	0.00710139	CS
52	-0.03024	-84.6110800224	0.03574	0.0384	0.0017	216691	0.02002248	CS
156	-0.0171	-75.6637168142	0.0226	0.06	0.0017	307612	0.02646563	CS
260	-0.0171	-75.6637168142	0.0226	0.06	0.0017	307612	0.02646563	CS

PTPI - Frequently Asked Questions (FAQ)

What is the current Petros Pharmaceuticals Inc (PK) share price?

The current share price of Petros Pharmaceuticals Inc (PK) is US$ 0,0055

How many Petros Pharmaceuticals Inc (PK) shares are in issue?

Petros Pharmaceuticals Inc (PK) has 42 372 260 shares in issue

What is the market cap of Petros Pharmaceuticals Inc (PK)?

The market capitalisation of Petros Pharmaceuticals Inc (PK) is USD 233,05k

What is the 1 year trading range for Petros Pharmaceuticals Inc (PK) share price?

Petros Pharmaceuticals Inc (PK) has traded in the range of US$ 0,0017 to US$ 0,0384 during the past year

What is the PE ratio of Petros Pharmaceuticals Inc (PK)?

The price to earnings ratio of Petros Pharmaceuticals Inc (PK) is -0,01

What is the registered address of Petros Pharmaceuticals Inc (PK)?

The registered address for Petros Pharmaceuticals Inc (PK) is 1185 Avenue of the Americas, New York, New York, 10036

What is the Petros Pharmaceuticals Inc (PK) website address?

The website address for Petros Pharmaceuticals Inc (PK) is petrospharma.com

Which industry sector does Petros Pharmaceuticals Inc (PK) operate in?

Petros Pharmaceuticals Inc (PK) operates in the Pharmaceuticals sector

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Petros Pharmaceuticals Inc (PK) (PTPI)

Petros Pharmaceuticals Inc (PK) (PTPI) Action

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de Petros Pharmaceuticals Inc (PK)

PTPI Dernières nouvelles

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

PTPI - Frequently Asked Questions (FAQ)

PTPI Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Sign up for FREE and get:

Supprimer les publicités